What is the treatment for papular urticaria?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Papular urticaria is best treated with a combination of avoiding the insect causing the bites, topical treatments, and oral medications for symptom relief, with the most recent guidelines suggesting the use of antihistamines as the first-line treatment, and omalizumab or cyclosporine for more severe cases 1. The treatment approach should prioritize the patient's quality of life, morbidity, and mortality, and the choice of treatment should be based on the severity of the symptoms and the patient's response to previous treatments. Some key considerations in the treatment of papular urticaria include:

  • Identifying and eliminating the source of bites by cleaning living spaces, washing bedding in hot water, and using insect repellents
  • Applying topical corticosteroids like hydrocortisone 1% cream to affected areas 2-3 times daily for up to 2 weeks to reduce inflammation and itching
  • Using oral antihistamines such as cetirizine (10mg daily), loratadine (10mg daily), or diphenhydramine (25-50mg every 6 hours) to control itching
  • Considering the use of omalizumab or cyclosporine for more severe cases, as recommended by the most recent guidelines 1
  • Monitoring the patient's response to treatment and adjusting the treatment plan as needed to minimize morbidity, mortality, and improve quality of life. It is also important to note that the treatment of papular urticaria should be individualized, and the patient's specific needs and circumstances should be taken into account when developing a treatment plan, as suggested by the guidelines 1.

From the FDA Drug Label

Uses temporarily relieves itching associated with minor skin irritations, inflammation, and rashes due to: eczema psoriasis poison ivy, oak, sumac insect bites detergents jewelry cosmetics soaps seborrheic dermatitis Directions for itching of skin irritation, inflammation, and rashes: adults and children 2 years of age and older: apply to affected area not more than 3 to 4 times daily

  • Papular urticaria is a type of skin irritation caused by insect bites, which is listed as one of the uses for hydrocortisone (TOP) 2 and 2.
  • The treatment for papular urticaria using hydrocortisone (TOP) involves applying the medication to the affected area not more than 3 to 4 times daily for adults and children 2 years of age and older.
  • For children under 2 years of age, it is recommended to ask a doctor before applying hydrocortisone (TOP) 2.

From the Research

Treatment Options for Papular Urticaria

  • The mainstay of treatment for urticaria, including papular urticaria, is avoidance of triggers, if identified 3.
  • Second-generation H1 antihistamines are the first-line pharmacotherapy for urticaria, which can be titrated to greater than standard doses 3, 4, 5.
  • First-generation H1 antihistamines, H2 antihistamines, leukotriene receptor antagonists, high-potency antihistamines, and brief corticosteroid bursts may be used as adjunctive treatment for urticaria 3, 4, 6.
  • For refractory chronic urticaria, patients can be referred to subspecialists for additional treatments, such as omalizumab or cyclosporine 3, 5, 6.

Specific Considerations for Papular Urticaria

  • Papular urticaria is a common and often distressing childhood disorder manifested by chronic or recurrent papules caused by a hypersensitivity reaction to the bites of mosquitoes, fleas, bedbugs, and other insects 7.
  • The histopathology of papular urticaria consists of mild subepidermal edema, extravasation of erythrocytes, interstitial eosinophils, and exocytosis of lymphocytes 7.
  • Non-pharmacotherapeutic means to minimize hyper-responsive skin are also important and recommended, such as prevention skin from drying, avoidance of hot shower, scrubbing, and excessive sun exposure 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Acute and Chronic Urticaria: Evaluation and Treatment.

American family physician, 2017

Research

Treatment of urticaria. An evidence-based evaluation of antihistamines.

American journal of clinical dermatology, 2001

Research

Clinical practice guideline for diagnosis and management of urticaria.

Asian Pacific journal of allergy and immunology, 2016

Research

Diagnosis and treatment of urticaria in primary care.

Northern clinics of Istanbul, 2019

Research

Papular urticaria.

Cutis, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.